Predictors of Pneumococcal Conjugate Vaccine Immunogenicity among Infants and Toddlers in an American Indian PnCRM7 Efficacy Trial
Author(s) -
Katherine L. O’Brien,
Jennifer C. Moïsi,
Lawrence H. Moulton,
Dace V. Madore,
Angelia A. Eick,
Ray Reid,
Robert Weatherholtz,
Eugene V. Millar,
Diana Hu,
Jill Hackell,
Robert Kohberger,
George R. Siber,
Mathuram Santosham
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/518438
Subject(s) - immunogenicity , pneumococcal conjugate vaccine , medicine , antibody , serotype , immunology , conjugate , immune system , streptococcus pneumoniae , biology , microbiology and biotechnology , antibiotics , mathematical analysis , mathematics
Pneumococcal conjugate vaccines are important for the prevention of serious illness and death among infants. Factors associated with pneumococcal conjugate vaccine immunogenicity have not been explored.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom